Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

FDA approves wireless contact lens sensor

Triggerfish allows monitoring of eye pressure for 24 hours

Sensimed contact lens sensor 

A single use contact lens that has a tiny sensor embedded to wirelessly send eye pressure data for up to 24-hours has won US approval.

The FDA granted a marketing licence to the Sensimed's Triggerfish system, which measures tiny changes or fluctuations in an eye's volume.

The Swiss firm's contact lens sensor transmits data to an adhesive antenna worn around the eye, and this in turn sends the information to a portable data recorder worn by the patient.

Completing the information chain, the recorder can then transfer the data via Bluetooth to a clinician's computer.

The FDA said the device may help healthcare professionals identify the best time of day to measure a patient's intraocular pressure, elevated levels of which are often associated with the optic nerve damage characteristic of glaucoma.

William Maisel, acting director of the Office of Device Evaluation in the FDA's Center for Devices and Radiological Health, said: “The Triggerfish gives the clinician 24-hour continuous monitoring of changes in IOP patterns that otherwise could not be obtained.

“This information can help determine the most critical time of day for the clinician to measure the patient's IOP.”

Glaucoma is a leading cause of vision loss and affects an estimated three million people in the US with many suffering no symptoms until significant and irreversible vision loss.

FDA approval came after the US regulator reviewed the product through its de novo premarket review pathway, a regulatory pathway for some low- to moderate-risk medical devices that are not substantially equivalent to an already legally-marketed device.

Triggerfish is approved in Europe, where it has a CE mark, and its new US approval is for its use in adults age 22 and older under the direction and supervision of a health care professional.

Wearable sensors are attracting increasing attention in healthcare, where the front-runners include UCB, which has begun trials of a wearable sensor to monitor the symptoms of Parkinson's disease, and Proteus' ingestible 'digital medicine'.

In eye care Novartis has licensed the rights to Google's smart lens technology and is developing it for use in diabetes and presbyopia, with clinical trials due to begin later this year.

7th March 2016

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

BrAInPME.png
The future of medical content: The personal touch
The purpose of delivering personalised content to HCPs is not just about customer experience, it's about improving healthcare. Our Commercial Director, Tib Catania discusses what ‘deep learning’ means for the...
Rise of the patient expert - an interview with Michael Seres
Founded by Michael Seres in 2011, 11 Health is a connected medical device company currently working to change the lives of patients using stoma bags. Content Marketing Manager Liz Inskip...
Making sense of Nutraceuticals in China
Published in eyeforpharma February 2017 by Marc Yates...

Infographics